Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Change of operational policy

<< Previous

Bullboard Posts

Next >>

Comment by SironaInvestoron Dec 09, 2022 12:30pm

128 Views

Post# 35161963

RE:RE:RE:RE:RE:RE:RE:RE:RE:Change of operational policy

I'm still 100% sure that you are working for Sirona or PRC. No words about all the disappointments in the past from you. Everything is always pretty nice for you. A promised Q&A will be probably taken place after the AGM so no chance again for all of us to raise the hand before.
Have you seen the Sedar filling about the new option Plan? Have you read that? Any guess what that mean?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario